Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2010-04-02
Product name
Strep A CONTROL +
Product Synonyms
OSOM® Strep A Positive Control
CAS No.
26628-22-8
1.2.1 Relevant identified uses
Component of OSOM® Strep A Test and OSOM® Ultra Strep A Test. For external quality control testing. For In Vitro Diagnostic Use Only Corporate Headquarters
Icons in SDS
Company Information
company name
Genzyme Diagnostics
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Regulatory status This preparation is not classified as hazardous under U.S. OSHA 29 CFR 1910.1200. This medical diagnostic kit is controlled under the Canadian Food and Drugs Act and is exempt from classification, labeling and MSDS requirements under the Canadian Hazardous Products Act and Controlled Products Regulations.
Precautionary statements
CAUTION! The chemical, physical and toxicological properties of this preparation have not been thoroughly characterized. Avoid contact with eyes and skin. Do not ingest or inhale. Preparation appearance: clear, colorless liquid.
Potential health effects
Inhalation No data available. Eyes No data available. Eye exposure may cause irritation, redness and watering. Skin No data available. Skin contact may cause irritation, dryness and redness. Sodium azide may be absorbed through the skin and result in systemic effects. Ingestion Ingestion of sodium azide may cause nausea, diarrhea, vomiting, headache, slight lowering of blood pressure, abdominal pain, and a general feeling of apprehension and unwellness.
Potential chronic health
No data available. Target organs Sodium azide: Cardiovascular and central nervous system.
Environmental effects
See Section 12.
